Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
about
Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment studyChronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALSLenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegenerationGalectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.Optical, spectroscopic, and Doppler evaluation of "normal" and "abnormal" reflexology areas in lumbar vertebral pathology: a case studyElevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine.Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS)Early elevation in random plasma IL-6 after severe injury is associated with development of organ failureTranscription factor p53 influences microglial activation phenotypeThe Role of immune and inflammatory mechanisms in ALS.Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicityHumoral factors in ALS patients during disease progression.Complex Inflammation mRNA-Related Response in ALS Is Region DependentHIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND.Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.Th17 Cell Response in SOD1G93A Mice following Motor Nerve InjuryT cells in amyotrophic lateral sclerosis.RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases.Protein biomarkers for amyotrophic lateral sclerosis.Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trialHomocysteine levels and amyotrophic lateral sclerosis: A possible link.CSF markers in amyotrophic lateral sclerosis.Peripheral inflammation in neurodegeneration.Vitamin D as a potential therapy in amyotrophic lateral sclerosis.Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Melatonin suppresses proinflammatory mediators in lipopolysaccharide-stimulated CRL1999 cells via targeting MAPK, NF-κB, c/EBPβ, and p300 signaling.Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection.Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis.The roles of autophagy and hypoxia in human inflammatory periapical lesions.Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model.Intraspinal Transplantation of the Adipose Tissue-Derived Regenerative Cells in Amyotrophic Lateral Sclerosis in Accordance with the Current Experts' Recommendations: Choosing Optimal Monitoring Tools
P2860
Q22305776-7DE54BD0-A500-48A3-9361-4F4909247C9BQ27303112-9513BD65-CDA4-4B8E-91D6-E6A7DCF16FB5Q33500473-38ABB080-0586-4379-BE69-42F771F47DD8Q33767845-2BF86DD4-86DF-4D72-AFF5-4CAD5352F47CQ34050769-7236403E-1F83-44D5-BE0D-24D7F5A10505Q34168523-EF9260CE-11D4-4CB7-87FA-27FF76F194EEQ34568153-B985A9D8-3AB9-4179-A197-0A75066B18EFQ34652040-C25882A6-F520-439D-9620-06905C74C09DQ34698706-DB3F6CE2-B6BC-4EE1-A7BD-C5337B96B954Q35065087-E48747F5-4561-4037-91D7-F8CABA731263Q35127007-77E78614-6365-47A4-A775-58DFD0C3A15EQ35238394-C8C7CC7D-EC57-4E15-B007-4E0AB8DA4F8BQ35562672-D259D9DC-6BCB-4E79-8BB4-8FDFDEB9882AQ35806256-4C45B2C2-4387-4BE3-A4FC-EBDFCC90D910Q35957868-334ADECB-D3A3-4871-9F86-D03F311F5236Q36185385-AC7DB309-9904-4B43-AC53-CE1AAD3D72BCQ36330960-5B5E4F79-D9D5-487D-9ABC-14A04F8BDC3AQ36576416-4A8DBC72-0238-43B7-9E25-B76F624D8C06Q36663923-8CF7E576-1B4A-4E5B-8C3B-5F804695A709Q36855551-054CCC5E-B771-458E-B3C0-7F64C81428FCQ37081721-C3D6D674-A785-492C-A139-3702D18B5FEFQ37148589-8568356E-178C-410C-B8B1-040FAD68ECCFQ37157841-18CBABC4-3226-457E-8583-4D43115BA16FQ37288200-D105A540-9B48-476D-B9F6-E702759144FAQ37529527-0ED4B5F5-693B-4B02-AE48-1D95A21B6FF3Q38007362-37003299-A016-4CE2-BFFD-9F5F5D50A4F5Q38094970-1BF4A123-F192-45D0-8DB1-81BE9521D2FAQ38178758-EC175383-AE8F-42FE-9FDE-74828AC87547Q38542939-6D169A57-AA11-4AE3-BA8A-AA51C47D5221Q38613326-79EF7B77-484A-44E5-BCF5-979D017CDD5AQ38701186-69A7ECCB-2775-427D-A87F-311EDD9C424EQ39033841-D9D4B303-65CF-455F-9182-4DD7A6A3A063Q39393886-C0B666E2-21CF-4B63-9A87-65568B62DA33Q39990782-2F5B446D-9503-4B20-B7BC-D9261796A247Q41585035-6D7CDECA-B3D0-4FE3-A7C4-7DC8A823C656Q42323404-00C0F976-5B39-4F9B-88D1-2EE7B183A8A2Q47829271-792B9FE9-971E-424B-86B5-2EF25B8202B1Q48236654-531A0F72-860C-43BA-8F36-2B9769703277Q48237902-A2689EAB-0FA5-4BAF-8AE8-841388C98F08Q58787909-629D5E5A-7D02-4A7B-93D5-489ECEF7FF39
P2860
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@en
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@nl
type
label
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@en
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@nl
prefLabel
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@en
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@nl
P2093
P921
P1433
P1476
Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
@en
P2093
A B Tonnel
P Lassalle
V Brunaud-Danel
P304
P356
10.1212/01.WNL.0000188907.97339.76
P407
P577
2005-12-01T00:00:00Z